This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cystic_fibrosis [01.26.2019] – [Evidence of infectious cause] sallieq | home:diseases:cystic_fibrosis [02.18.2019] – [Evidence of infectious cause] sallieq | ||
---|---|---|---|
Line 13: | Line 13: | ||
===== Evidence of infectious cause ===== | ===== Evidence of infectious cause ===== | ||
+ | Pseudomonal infection in cystic fibrosis: the battle continues.(({{pubmed> | ||
+ | < | ||
+ | Pseudomonas aeruginosa lung infection is the major cause of morbidity and mortality in patients with cystic fibrosis. Infection usually begins in childhood and is responsible for respiratory failure and death in most patients with cystic fibrosis. The organism triggers an exuberant chronic inflammatory reaction which damages the airways and leads to progressive loss of lung function. | ||
- | Expert Rev Anti Infect Ther. 2003 Dec; | + | This review provides an overview of pseudomonal |
- | Pseudomonal | + | |
- | Elkin S, Geddes D. | + | |
- | Department | + | Evolution |
- | Pseudomonas aeruginosa lung infection is the major cause of morbidity and mortality in patients | + | < |
- | (({{pubmed> | + | |
+ | | ||
+ | </ | ||
+ | |||
+ | ChIP-seq reveals the global regulator AlgR mediating cyclic di-GMP synthesis in Pseudomonas aeruginosa | ||
+ | < | ||
+ | |||
+ | A ΔalgR strain produced lesser biofilm than did the wild-type strain, which is consistent with a phenotype controlled by c-di-GMP. | ||
+ | </ | ||
+ | |||
+ | |||
+ | | ||
{{tag> | {{tag> | ||
- | < | ||
===== Notes and comments ===== | ===== Notes and comments ===== |